Alternatives to Ambrx

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

A global oncology company developing and commercializing innovative cancer treatments.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Genomics and AI-driven health intelligence company focused on extending healthy human life.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Developing a new histotripsy therapeutic platform for cancer treatment.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.